Study Title: A Phase 3 Randomized Non Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727, IND# 77782) in Newly Diagnosed or Previously Untreated Low Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Kraveka, Jacqueline, at kravekjm@musc.edu.Study Coordinator, Helfrey, Lauren, at helfrey@musc.edu.Trial opened at the following institutions: Medical University of South Carolina